Federal Data HubHRSA 340B · JSON

Connecticut Children's Hemophilia Treatment Center

340B ID HM06032

ParticipatingHemophilia Treatment Center

Connecticut Children's Hemophilia Treatment Center is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in Farmington, CT. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 10 contract-pharmacy arrangement(s) (9 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (10)

PharmacyLocationBeginTerminatedPharmacy ID
ACCREDO HEALTH GROUP INCTEMPE, AZ2020-04-0175292
ACCREDO HEALTH GROUP INCWARRENDALE, PA2020-04-0123041
ACCREDO HEALTH GROUP INCMEMPHIS, TN2020-04-0145979
ACCREDO HEALTH GROUP, INC.NEWARK, DE2020-04-0198337
ACCREDO HEALTH GROUP, INC.ORLANDO, FL2020-04-0139194
ACCREDO HEALTH GROUP, INC.INDIANAPOLIS, IN2020-04-012023-10-0151763
ACCREDO HEALTH GROUP, INC.LENEXA, KS2020-04-0162883
ACCREDO HEALTH GROUP, INC.PINE BROOK, NJ2020-04-0116515
POSITUDES INCWESTBURY, NY2026-01-018621
SUPERIOR BIOLOGICS NY INCHAWTHORNE, NY2020-04-0110857

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.